febuxostat has been researched along with Atrophy, Muscle in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izuhara, L; Kamatani, N; Maejima, Y; Mashima, R; Mitani, S; Yoshina, S | 1 |
| Anzai, T; Fukushima, A; Furihata, T; Higashikawa, K; Kakutani, N; Katayama, T; Kinugawa, S; Kuge, Y; Maekawa, S; Matsumoto, J; Nakajima, T; Nakano, I; Nambu, H; Nio-Kobayashi, J; Obata, Y; Sabe, H; Saito, A; Shirakawa, R; Takada, S; Tsuda, M; Yamanashi, K; Yasui, H; Yokota, T | 1 |
2 other study(ies) available for febuxostat and Atrophy, Muscle
| Article | Year |
|---|---|
Febuxostat ameliorates muscle degeneration and movement disorder of the dystrophin mutant model in Caenorhabditis elegans.
Topics: Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Dystrophin; Febuxostat; Movement Disorders; Muscles; Muscular Atrophy | 2023 |
Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance.
Topics: Animals; Cell Hypoxia; Cell Line; Disease Models, Animal; Enzyme Inhibitors; Exercise Tolerance; Febuxostat; Male; Mice, Inbred C57BL; Mitochondria, Muscle; Muscle Fibers, Skeletal; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Myocardial Infarction; Reactive Oxygen Species; Ribosomal Protein S6 Kinases, 70-kDa; Time Factors; TOR Serine-Threonine Kinases; Xanthine Oxidase | 2021 |